Shares of PaxMedica (NASDAQ:PXMD) shot up 125% in post-market trading Thursday after the company announced it had completed execution of three registration/validation batches of its drug PAX-101, an ...
Source LinkShares of PaxMedica (NASDAQ:PXMD) shot up 125% in post-market trading Thursday after the company announced it had completed execution of three registration/validation batches of its drug PAX-101, an ...
Source Link
Comments